Heterogeneity in Fragile X Syndrome Highlights the Need for Precision Medicine-Based Treatments

Heterogeneity in Fragile X Syndrome Highlights the Need for Precision Medicine-Based Treatments

Fragile X syndrome (FXS) is the most frequent monogenic cause of autism or intellectual disability, and research on its pathogenetic mechanisms has provided important insights on this neurodevelopmental condition. Nevertheless, after 30 years of intense research, efforts to develop treatments have b...

Full description

Bibliographic Details
Main Authors: Edgard Verdura, Laura Pérez-Cano, Rubén Sabido-Vera, Emre Guney, Jean-Marc Hyvelin, Lynn Durham, Baltazar Gomez-Mancilla
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Psychiatry
Subjects:
Fragile X syndrome
precision medicine-based treatments
autism spectrum disorders
biomarkers
monogenic disease
heterogeneity
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.722378/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.722378/full

Similar Items